RetractedTrialJournal of healthcare engineering2022

Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma.

Yibo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.